sponsored by the National Natural Science Foundation of China(Grant No.82273691);the Natural Science Foundation of Jiangsu Province(Grant No.BK20190106);the Nanjing Important Science&Technology Specific Projects(Grant No.2021-11005);the National Natural Youth Science Foundation of China(Grant No.81703273);the Priority Academic Program Development of Jiangsu Higher Education Institutions.
Despite achieving a high cure rate with the direct-acting antivirals(DAAs)in hepatitis C treatment,further research is needed to identify additional benefits of the DAA therapy.The current study evaluated liver fibros...